APA (7th ed.) Citation

Plock, N., Vollert, S., Mayer, M., Hanauer, G., & Lahu, G. (2017). Pharmacokinetic/Pharmacodynamic Modeling of the PDE4 Inhibitor TAK-648 in Type 2 Diabetes: Early Translational Approaches for Human Dose Prediction. CTS: Clinical & Translational Science, 10(3), 185. https://doi.org/10.1111/cts.12436

Chicago Style (17th ed.) Citation

Plock, N., S. Vollert, M. Mayer, G. Hanauer, and G. Lahu. "Pharmacokinetic/Pharmacodynamic Modeling of the PDE4 Inhibitor TAK-648 in Type 2 Diabetes: Early Translational Approaches for Human Dose Prediction." CTS: Clinical & Translational Science 10, no. 3 (2017): 185. https://doi.org/10.1111/cts.12436.

MLA (9th ed.) Citation

Plock, N., et al. "Pharmacokinetic/Pharmacodynamic Modeling of the PDE4 Inhibitor TAK-648 in Type 2 Diabetes: Early Translational Approaches for Human Dose Prediction." CTS: Clinical & Translational Science, vol. 10, no. 3, 2017, p. 185, https://doi.org/10.1111/cts.12436.